In our study, the GSEA pathway-based supervised analysis of sporadic, PGL2 – and SDHD -linked paragangliomas did not reveal significant differences between the subgroups for all GSEA gene sets, including the gene sets that characterized SDH tumors in the study by Dahia et al.[9]. The gene discussed is SDHD; the disease is paraganglioma.